Cure Models as a Useful Statistical Tool for Analyzing Survival von OTHUS, Megan, BARLOGIE, Bart, LEBLANC, Michael L, CROWLEY, John J

Volltext

Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736 von Stephens, Deborah M, Li, Hongli, LeBlanc, Michael L, Puvvada, Soham D, Persky, Daniel, Friedberg, Jonathan W, Smith, Sonali M

Volltext

Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 von Stephens, Deborah M., Li, Hongli, Constine, Louis S., Fitzgerald, Thomas J., Leonard, John P., Kahl, Brad S., Song, Joo Y., LeBlanc, Michael L., Smith, Sonali M., Persky, Daniel O., Friedberg, Jonathan W.

Volltext

Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001 von Persky, Daniel O, Li, Hongli, Stephens, Deborah M, Park, Steven I, Bartlett, Nancy L, Swinnen, Lode J, Barr, Paul M, Winegarden, 3rd, Jerome D, Constine, Louis S, Fitzgerald, Thomas J, Leonard, John P, Kahl, Brad S, LeBlanc, Michael L, Song, Joo Y, Fisher, Richard I, Rimsza, Lisa M, Smith, Sonali M, Miller, Thomas P, Friedberg, Jonathan W

Volltext

Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma von Kamdar, Manali, Li, Hongli, Chen, Robert W., Rimsza, Lisa M., Leblanc, Michael L., Fenske, Timothy S., Shea, Thomas C., Barr, Paul M., Phillips, Tycel J., Leonard, John P., Kahl, Brad S., Friedberg, Jonathan W., Smith, Sonali M.

Volltext

Estimating individualized treatment rules by optimizing the adjusted probability of a longer survival von He, Qijia, Zhang, Shixiao, LeBlanc, Michael L, Zhao, Ying-Qi

Volltext

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol von Redman, Mary W, Papadimitrakopoulou, Vassiliki A, Minichiello, Katherine, Hirsch, Fred R, Mack, Philip C, Schwartz, Lawrence H, Vokes, Everett, Ramalingam, Suresh, Leighl, Natasha, Bradley, Jeff, Miao, Jieling, Moon, James, Highleyman, Louise, Miwa, Crystal, LeBlanc, Michael L, Malik, Shakun, Miller, Vincent A, Sigal, Ellen V, Adam, Stacey, Wholley, David, Sigman, Caroline, Smolich, Beverly, Blanke, Charles D, Kelly, Karen, Gandara, David R, Herbst, Roy S

Volltext

Long-Term Effects of Finasteride on Prostate Cancer Mortality von Goodman, Phyllis J, Tangen, Catherine M, Darke, Amy K, Lucia, M. Scott, Ford, Leslie G, Minasian, Lori M, Parnes, Howard L, LeBlanc, Michael L, Thompson, Ian M

Volltext

Designing precision medicine trials to yield a greater population impact von Zhao, Ying‐Qi, LeBlanc, Michael L.

Volltext

A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphoma von Rimsza, Lisa M, Unger, Joseph M, Tome, Margaret E, Leblanc, Michael L

Volltext

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials von Rutherford, Sarah C, Yin, Jun, Pederson, Levi, Perez Burbano, Gabriela, LaPlant, Betsy, Shadman, Mazyar, Li, Hongli, LeBlanc, Michael L, Kenkre, Vaishalee P, Hong, Fangxin, Blum, Kristie A, Dockter, Travis, Martin, Peter, Jung, Sin-Ho, Grant, Barbara, Rosenbaum, Cara, Ujjani, Chaitra, Barr, Paul M, Unger, Joseph M, Cheson, Bruce D, Bartlett, Nancy L, Kahl, Brad, Friedberg, Jonathan W, Mandrekar, Sumithra J, Leonard, John P

Volltext

Restricted survival benefit with right‐censored data von Zhang, Shixiao, LeBlanc, Michael L., Zhao, Ying‐Qi

Volltext

Reply to E. Hawkes et al von Persky, Daniel O, Smith, Sonali M, LeBlanc, Michael L, Friedberg, Jonathan W

Volltext

Exploring interactions in high-dimensional genomic data: an overview of Logic Regression, with applications von Ruczinski, Ingo, Kooperberg, Charles, L. LeBlanc, Michael

Volltext

Quantifying treatment effects using the personalized chance of longer survival von Zhao, Ying‐Qi, Redman, Mary W., LeBlanc, Michael L.

Volltext

Robustifying Trial-Derived Optimal Treatment Rules for A Target Population von Zhao, Ying-Qi, Zeng, Donglin, Tangen, Catherine M, LeBlanc, Michael L

Volltext

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma von Roberts, Robin A, Sabalos, Constantine M, LeBlanc, Michael L, Martel, Ralph R, Frutiger, Yvette M, Unger, Joseph M, Botros, Ihab W, Rounseville, Matthew P, Seligmann, Bruce E, Miller, Thomas P, Grogan, Thomas M, Rimsza, Lisa M

Volltext

The New NCI Precision Medicine Trials von Harris, Lyndsay N, Blanke, Charles D, Erba, Harry P, Ford, James M, Gray, Robert J, LeBlanc, Michael L, Hu-Lieskovan, Siwen, Litzow, Mark R, Luger, Selina M, Meric-Bernstam, Funda, O'Dwyer, Peter J, Othus, Megan K D, Politi, Katerina, Shepherd, Lois E, Allegra, Carmen J, Chen, Helen X, Ivy, S Percy, Korde, Larissa A, Little, Richard F, McShane, Lisa M, Moscow, Jeffrey A, Patton, David R, Thurin, Magdalena, Yee, Laura M, Doroshow, James H

Volltext

Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee von PALLER, Channing J, BRADBURY, Penelope A, REEVES, Steven, ELLIS, Lee M, SARGENT, Daniel J, ROSNER, Gary L, LEBLANC, Michael L, RATAIN, Mark J, IVY, S. Percy, SEYMOUR, Lesley, LORUSSO, Patricia M, BAKER, Laurence, RUBINSTEIN, Larry, HUANG, Erich, COLLYAR, Deborah, GROSHEN, Susan

Volltext

Dose-Intense Chemotherapy Every 2 Weeks With Dose-Intense Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone May Improve Survival in Intermediate- and High-Grade Lymphoma:... von BLAYNEY, Douglas W, LEBLANC, Michael L, GROGAN, Thomas, GAYNOR, Ellen R, CHAPMAN, Robert A, SPIRIDONIDIS, C. Harris, TAYLOR, Sarah A, BEARMAN, Scott I, MILLER, Thomas P, FISHER, Richard I

Volltext